← Leaderboards
Joaquina C Baranda
University Of Kansas Medical Center
$499,317
Attributed
$499,317
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $159.6K · FY2019–25$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$499,317 · 2
By mechanism
R50$319,148 · 1
P30$180,169 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- Edward F Ellerbeck$14,967,515
- Amanda N. Szabo-Reed$3,633,480
- Eric Dennis Vidoni$8,219,970
Others in their field
Other Emerging Leaders on “Early Phase Trial”
- Ted Ross · University Of Georgia$68,763,143
- Susan Abushakra · Alzheon, Inc.$51,190,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,555,942
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- James Dale Berry · Brigham And Women'S Hospital$21,103,231
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
Research focus
Early Phase TrialClinical TrialsCatchment AreaSiteCancer TherapyClinical Trials NetworkInvestigational TherapiesMedicalEarly Phase Clinical TrialCancer CenterProgramsUniversitiesDrug DevelopmentCancer Center Support GrantActivated Protein C ReceptorCritiquesDetectionClinical ResearchAccelerationCommunitiesDevicesDesignClinical DevelopmentClinical Data
Grant awards (5)
Increasing Access and Participation to Early Phase Clinical Trials$159,574
R50 · FY2025 · CA · contact PI
Increasing Access and Participation to Early Phase Clinical Trials to the Underrepresented Populations$159,574
R50 · FY2024 · CA · contact PI
Early Phase Clinical Research Support$61,229
P30 · FY2021 · CA · contact PI
Early Phase Clinical Research Support$60,049
P30 · FY2020 · CA · contact PI
Early Phase Clinical Research Support$58,891
P30 · FY2019 · CA · contact PI